Browse our press releases and news coverage.
For more information or to request a press pack, contact our Head of PR, Courtney Glymph
Synthace Team
Synthace and IDBS have entered a strategic partnership to provide state-of-the-art data foundations for experimentation in HTPD
Horizons Ventures and Sofinnova Partners Co-Lead Investment in Market-leading Life Sciences Software Company That Transforms the Way Scientists Autom
First ever no-code platform lowers barriers to automated biological experimentation and insight sharing.
Jan 2022- This paper describes a statistical Design of Experiments analysis of 20 components of a popular cell-free protein synthesis reaction buffer, and identifies factors and factor interactions that impact on protein yield, rate of reaction, lag time and reaction longevity.
Dec 21, 2021- IDBS and Synthace have entered into a strategic partnership to provide IDBS Polar™ users with state-of-the-art data foundations for experimentation in high-throughput process development.
Dec 2, 2021- Synthace has raised $35 million in Series C funding. The investment will fuel commercial and go-to-market growth as Synthace continues to radically reinvent the full value chain of life sciences R&D.
